El‐Sayed Khafagy
Impact in
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Drug Discovery top 1%
Papers in
-
- Advanced Drug Delivery Systems 35
- Advancements in Transdermal Drug Delivery 17
- Drug Solubulity and Delivery Systems 16
- Biomaterials 15
- Nanoparticle-Based Drug Delivery 14
- Co-authors
- Mariko Morishita (7 shared papers)Amr Selim Abu Lila (60 shared papers)Kozo Takayama (6 shared papers)Wael A. H. Hegazy (33 shared papers)Yoshinori Onuki (1 shared paper)Noriyasu Kamei (11 shared papers)Afrasim Moin (22 shared papers)Mohammed F. Aldawsari (19 shared papers)
- Journals
- Pharmaceutics (9 papers)Polymers (6 papers)Gels (6 papers)Pharmaceuticals (5 papers)Journal of Drug Delivery Science and Technology (4 papers)
- Partner nations
- EgyptSaudi ArabiaIndia
In The Last Decade
El‐Sayed Khafagy
124 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 99
- Pharmaceutical Science 1.4k
- Drug Discovery 35
- Biomaterials 535
- Molecular Medicine 127
- Neurology 130
Countries citing papers authored by El‐Sayed Khafagy
This map shows the geographic impact of El‐Sayed Khafagy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by El‐Sayed Khafagy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites El‐Sayed Khafagy more than expected).
Fields of papers citing papers by El‐Sayed Khafagy
This network shows the impact of papers produced by El‐Sayed Khafagy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by El‐Sayed Khafagy. The network helps show where El‐Sayed Khafagy may publish in the future.
Co-authors
The 25 scholars most cited alongside El‐Sayed Khafagy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 373 | |
| 2 | 2012 | 157 | |
| 3 | 2014 | 132 | |
| 4 | 2016 | 132 | |
| 5 | 2021 | 115 | |
| 6 | 2008 | 114 | |
| 7 | 2023 | 95 | |
| 8 | 2009 | 78 | |
| 9 | 2021 | 66 | |
| 10 | 2022 | 59 | |
| 11 | 2021 | 58 | |
| 12 | 2021 | 57 | |
| 13 | 2022 | 57 | |
| 14 | 2021 | 54 | |
| 15 | 2021 | 54 | |
| 16 | 2010 | 52 | |
| 17 | 2013 | 52 | |
| 18 | 2010 | 49 | |
| 19 | 2022 | 49 | |
| 20 | 2021 | 47 |
About El‐Sayed Khafagy
El‐Sayed Khafagy is a scholar working on Pharmaceutical Science, Biomaterials, Molecular Biology, Molecular Medicine and Drug Discovery, having authored 130 papers that have together received 3.6k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (35 papers), Bacterial biofilms and quorum sensing (22 papers), Advancements in Transdermal Drug Delivery (17 papers), Drug Solubulity and Delivery Systems (16 papers), Nanoparticle-Based Drug Delivery (14 papers), Nanoparticles: synthesis and applications (8 papers), RNA Interference and Gene Delivery (7 papers) and Gold and Silver Nanoparticles Synthesis and Applications (5 papers). The work is most often cited by research in Pharmaceutical Science (1.4k citations), Drug Discovery (35 citations), Biomaterials (535 citations), Molecular Medicine (127 citations) and Neurology (130 citations). El‐Sayed Khafagy has collaborated with scholars based in Egypt, Saudi Arabia and India. Frequent co-authors include Mariko Morishita, Amr Selim Abu Lila, Kozo Takayama, Wael A. H. Hegazy, Yoshinori Onuki, Noriyasu Kamei, Afrasim Moin, Mohammed F. Aldawsari, Mariko Takeda‐Morishita and Ahmed Al Saqr. Their work appears in journals such as Pharmaceutics, Polymers, Gels, Pharmaceuticals and Journal of Drug Delivery Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.